Dexlansoprazole: delayed-release orally disintegrating tablets for the treatment of heartburn associated with non-erosive gastroesophageal reflux disease and the maintenance of erosive esophagitis.

Oldfield, Edward C; Parekh, Parth J; Johnson, David A

Oldfield, Edward C; Parekh, Parth J; Johnson, David A.

Afiliación

Oldfield EC; a Department of Internal Medicine , Eastern Virginia Medical School , Norfolk , VA , USA.
Parekh PJ; b Department of Internal Medicine, Division of Gastroenterology and Hepatology , Tulane University , New Orleans , LA , USA.
Johnson DA; c Department of Internal Medicine, Division of Gastroenterology , Eastern Virginia Medical School , Norfolk , VA , USA.

Expert Rev Gastroenterol Hepatol ; 10(10): 1083-1089, 2016 Oct.

Article en En | MEDLINE | ID: mdl-27580358

Palabras clave

Dexilant; Dexlansoprazole; erosive esophagitis; gastroesophageal reflux disease; non-erosive reflux disease; proton pump inhibitor

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Tipo de estudio: Risk_factors_studies Idioma: En Revista: Expert Rev Gastroenterol Hepatol Asunto de la revista: GASTROENTEROLOGIA Año: 2016 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google